At Angiotech, we are redefining success by striving to create novel medical solutions that elevate the standard of care and improve people's lives.
Angiotech is Redefining Success
- Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury. We are listed on both the TSX and NASDAQ stock exchanges (NASDAQ: ANPI, TSX: ANP). Read More...
If you are a Healthcare Professional and would like to learn more about Angiotech's products, please visit AngioEduPRO.com; Angiotech's Educational Resource for Healthcare Professionals.
Press Releases
- May 1st - Angiotech Expands Quill™ SRS Product Offering Receiving FDA 510(k) Approval for Smaller Size Diameters of Quill™ SRS PDO Read More...
- April 29th - Angiotech Announces Results for the First Quarter Ended March 31, 2008 Read More...
- All Press Releases
Highlights
- Angiotech to participate in Bank of America Health Care Conference in Las Vegas on May 14th Read More...
- Angiotech to webcast conference call discussing First Quarter Financial Results on April 29th Read More...
